Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar;65(2):87–108. PubMed PMID: 25651787.
   PubMed Web of Science ®Google Scholar
• Fakhry C, Westra WH, Wang SJ, et al. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer. 2017 May 1;123(9):1566–1575. PubMed PMID: 28241096; PubMed Central PMCID: PMCPMC5788020.
   PubMed Web of Science ®Google Scholar
• Speight PM, Epstein J, Kujan O, et al. Screening for oral cancer-a perspective from the global oral cancer forum. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Jun;123(6):680–687. PubMed PMID: 27727113.
   PubMed Web of Science ®Google Scholar
• Sargeran K, Murtomaa H, Safavi SMR, et al. Survival after diagnosis of cancer of the oral cavity. Br J Oral Maxillofac Surg. 2008 Apr;46(3):187–191. PubMed PMID: 18096283.
   PubMed Web of Science ®Google Scholar
• Markopoulos AK. Current aspects on oral squamous cell carcinoma. Open Dent J. 2012;6:126–130. PubMed PMID: 22930665; PubMed Central PMCID: PMCPMC3428647.
   PubMedGoogle Scholar
• Shah JP, Gil Z. Current concepts in management of oral cancer–surgery. Oral Oncol. 2009 Apr-May;45(4–5):394–401. . PubMed PMID: 18674952; PubMed Central PMCID: PMCPMC4130348.
   PubMed Web of Science ®Google Scholar
• Dik EA, Willems SM, Ipenburg NA, et al. Resection of early oral squamous cell carcinoma with positive or close margins: relevance of adjuvant treatment in relation to local recurrence: margins of 3 mm as safe as 5 mm. Oral Oncol. 2014 Jun;50(6):611–615. PubMed PMID: 24630900.
   PubMed Web of Science ®Google Scholar
• Bloebaum M, Poort L, Bockmann R, et al. Survival after curative surgical treatment for primary oral squamous cell carcinoma. J Craniomaxillofac Surg. 2014 Dec;42(8):1572–1576. PubMed PMID: 24636353.
   PubMed Web of Science ®Google Scholar
• Sun CC, Zhang L, Li G, et al. The lncRNA PDIA3P Interacts with miR-185-5p to modulate oral squamous cell carcinoma progression by targeting cyclin D2. Mol Ther Nucleic Acids. 2017 Dec 15;9:100–110. PubMed PMID: 29246288; PubMed Central PMCID: PMCPMC5626923.
   PubMedGoogle Scholar
• Lu T, Liu H, You G. Long non-coding RNA C5orf66-AS1 prevents oral squamous cell carcinoma through inhibiting cell growth and metastasis. Int J Mol Med. 2018 Dec;42(6):3291–3299. . PubMed PMID: 30280186; PubMed Central PMCID: PMCPMC6202082.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li H, Fan S, et al. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway. Cancer Biol Ther. 2019;20(4):444–453. PubMed PMID: 30404566; PubMed Central PMCID: PMCPMC6422516.
   PubMed Web of Science ®Google Scholar
• Liu HY, Lu SR, Guo ZH, et al. lncRNA SLC16A1-AS1 as a novel prognostic biomarker in non-small cell lung cancer. J Investig Med. 2019 Jul 31 PubMed PMID: 31371390. DOI:https://doi.org/10.1136/jim-2019-001080.
   Google Scholar
• Zhang X, Feng H, Li Z, et al. Application of weighted gene co-expression network analysis to identify key modules and hub genes in oral squamous cell carcinoma tumorigenesis. Onco Targets Ther. 2018;11:6001–6021. PubMed PMID: 30275705; PubMed Central PMCID: PMCPMC6157991.
   PubMed Web of Science ®Google Scholar
• Zhang X, Feng H, Li Z, et al. Aspirin is involved in the cell cycle arrest, apoptosis, cell migration, and invasion of oral squamous cell carcinoma. Int J Mol Sci. 2018 Jul 12;19(7). PubMed PMID: 30002310.
   Web of Science ®Google Scholar
• Liao P, Wang H, Tang YL, et al. The common costimulatory and coinhibitory signaling molecules in head and neck squamous cell carcinoma. Front Immunol. 2019;10:2457. PubMed PMID: 31708918; PubMed Central PMCID: PMCPMC6819372.
   PubMed Web of Science ®Google Scholar
• Song MJ, Zhong AL, Yang JY, et al. Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma [Article]. Aging-US. 2019 Nov;11(22):10422–10453. PubMed PMID: WOS:000499683800033; English.
   Web of Science ®Google Scholar
• Troiano G, Caponio VCA, Botti G, et al. Immunohistochemical Analysis Revealed a Correlation between Musashi-2 and Cyclin-D1 Expression in Patients with Oral Squamous Cells Carcinoma [Article]. Int J Mol Sci. 2020 Jan;21(1):9. doi:10.3390/ijms21010121. PubMed PMID: WOS:000515378000121.
   Google Scholar
• Li Z, Wang C, Jiao X, et al. Cyclin D1 regulates cellular migration through the inhibition of thrombospondin 1 and ROCK signaling. Mol Cell Biol. 2006 Jun;26(11):4240–4256. PubMed PMID: 16705174; PubMed Central PMCID: PMCPMC1489104.
   PubMed Web of Science ®Google Scholar
• Li GH, Ma ZH, Wang X. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/beta-catenin signaling pathway. Cell Cycle. 2019 Nov;18(21):2902–2913. . PubMed PMID: 31599709; PubMed Central PMCID: PMCPMC6791703.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ma H, Zhang D, et al. LncRNA KCNQ1OT1 regulates proliferation and cisplatin resistance in tongue cancer via miR-211-5p mediated Ezrin/Fak/Src signaling. Cell Death Dis. 2018 Jul 3;9(7):742. 10.1038/s41419-018-0793-5. PubMed PMID: 29970910; PubMed Central PMCID: PMCPMC6030066.
   PubMedGoogle Scholar
• Kumar P, Khadirnaikar S, Shukla SK. A novel LncRNA-based prognostic score reveals TP53-dependent subtype of lung adenocarcinoma with poor survival. J Cell Physiol. 2019 Feb 10. PubMed PMID: 30740686.
   Web of Science ®Google Scholar
• Long J, Wang A, Bai Y, et al. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine. 2019 Apr;42:363–374. PubMed PMID: 30885723; PubMed Central PMCID: PMCPMC6491941.
   PubMed Web of Science ®Google Scholar
• Martinez E, Yoshihara K, Kim H, et al. Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects. Oncogene. 2015 May 21;34(21):2732–2740. PubMed PMID: 25088195; PubMed Central PMCID: PMCPMC4317393.
   PubMed Web of Science ®Google Scholar
• Pruszko M, Milano E, Forcato M, et al. The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1. EMBO Rep. 2017 Aug;18(8):1331–1351. PubMed PMID: 28652379; PubMed Central PMCID: PMCPMC5538427.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Li Y, Sheng J, et al. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs. J Exp Clin Cancer Res. 2019 Aug 28;38(1):379. PubMed PMID: 31455383; PubMed Central PMCID: PMCPMC6712617.
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen L, Gu J, et al. Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nat Commun. 2017 Feb 13;8:14421. PubMed PMID: 28194035; PubMed Central PMCID: PMCPMC5316832.
   PubMed Web of Science ®Google Scholar
• Yu WD, Wang H, He QF, et al. Long noncoding RNAs in cancer-immunity cycle. J Cell Physiol. 2018 Sep;233(9):6518–6523. PubMed PMID: 29574911.
   PubMed Web of Science ®Google Scholar
• Huang D, Chen J, Yang L, et al. NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death. Nat Immunol. 2018 Oct;19(10):1112–1125. 10.1038/s41590-018-0207-y. PubMed PMID: 30224822.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang H, Zheng Y, et al. The long noncoding RNA MALAT1 induces tolerogenic dendritic cells and regulatory T cells via miR155/Dendritic cell-specific intercellular adhesion Molecule-3 grabbing Nonintegrin/IL10 axis. Front Immunol. 2018;9:1847. PubMed PMID: 30150986; PubMed Central PMCID: PMCPMC6099154.
   PubMed Web of Science ®Google Scholar